| 1 (33) | Samsung Corp * | MUL |  |
| 2 (92) | F Hoffmann-La Roche * | MUL | |
| 3 (113) | Genentech Inc | USA | |
| 4 (119) | Hoffmann-La Roche Ltd, United States | USA | |
| 5 (137) | AstraZeneca * | MUL | |
| 6 (138) | Novartis Institutes for Biomedical Research, United States | USA | |
| 7 (153) | Bristol-Myers Squibb Company * | MUL | |
| 8 (163) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 9 (168) | Bristol-Myers Squibb Company, United States | USA | |
| 10 (170) | GlaxoSmithKline, United States | USA | |
| 11 (172) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 12 (176) | Sumitomo Group * | MUL | |
| 13 (199) | Sanofi, France | FRA | |
| 14 (205) | Pfizer * | MUL | |
| 15 (210) | Merck & Co Inc * | MUL | |
| 16 (215) | Novartis * | MUL | |
| 17 (220) | GlaxoSmithKline * | MUL | |
| 18 (230) | AstraZeneca, United Kingdom | GBR | |
| 19 (239) | Daiichi Sankyo Co., Ltd. * | MUL | |
| 20 (241) | Merck & Co Inc, United States | USA | |
| 21 (254) | Sanofi * | MUL | |
| 22 (256) | Boehringer Ingelheim * | MUL | |
| 23 (264) | Amgen * | MUL | |
| 24 (276) | Eli Lilly * | MUL | |
| 25 (279) | Johnson & Johnson * | MUL | |
| 26 (285) | Merck KGaA * | MUL | |
| 27 (308) | Pfizer Inc, United States | USA | |
| 28 (313) | Merck KGaA, Germany | DEU | |
| 29 (315) | Janssen | MUL | |
| 30 (321) | AbbVie * | MUL | |
| 31 (323) | Eli Lilly and Company, United States | USA | |
| 32 (326) | Bayer AG, Germany | DEU | |
| 33 (329) | Amgen, USA | USA | |
| 34 (340) | AstraZeneca, United States | USA | |
| 35 (358) | Bayer * | MUL | |
| 36 (361) | Sanofi, United States | USA | |
| 37 (364) | Pfizer Inc, Spain | ESP | |
| 38 (368) | Gilead Sciences * | MUL | |
| 39 (386) | AbbVie Inc, United States | USA | |
| 40 (410) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 41 (418) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 42 (428) | Regeneron Pharmaceuticals Inc * | USA | |
| 43 (430) | Gilead Sciences Inc, United States | USA | |
| 44 (431) | Robert Bosch * | MUL | |
| 45 (445) | Janssen Biotech Inc | USA | |
| 46 (476) | Koninklijke Philips NV * | MUL | |
| 47 (528) | Boehringer Ingelheim GmbH Germany | DEU | |
| 48 (538) | Foundation Medicine Inc | USA | |
| 49 (550) | Astellas Pharma Inc * | MUL | |
| 50 (717) | Roche Products Ltd, United Kingdom | GBR | |
| 51 (740) | Boehringer Ingelheim, USA | USA | |
| 52 (746) | Hitachi * | MUL | |
| 53 (777) | Novo Nordisk * | MUL | |
| 54 (788) | Takeda Pharmaceuticals International Inc * | MUL | |
| 55 (833) | Siemens * | MUL | |
| 56 (850) | Janssen Research & Development, LLC | BEL | |
| 57 (872) | Novartis, Switzerland | CHE | |
| 58 (919) | Bayer Corp, USA | USA | |
| 59 (939) | General Electric Company * | MUL | |
| 60 (949) | Novo Nordisk A/S | DNK | |
| 61 (962) | Translational Research Institute | AUS | |
| 62 (998) | Konica Minolta Inc * | MUL | |
| 63 (1227) | Analysis Group Inc | USA | |
| 64 (1249) | Novartis Pharmaceuticals, United States | USA | |
| 65 (1328) | IQVIA Inc * | MUL | |
| 66 (1375) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 67 (1387) | Bosch, Germany | DEU | |
| 68 (1436) | GE Healthcare | MUL | |
| 69 (1441) | Astellas Pharma Inc | JPN | |
| 70 (1471) | E United Group * | TWN | |
| 71 (1498) | GlaxoSmithKline, United Kingdom | GBR | |
| 72 (1505) | IQVIA, United States | USA | |
| 73 (1567) | Nippon Telegraph and Telephone Corporation * | MUL | |
| 74 (1590) | RTI International, United States | USA | |
| 75 (1609) | Nippon Telegraph and Telephone Corp, Japan | JPN | |
| 76 (1997) | Manipal Global Education Group * | MUL | |
| 77 (2095) | Siemens AG, Germany | DEU | |
| 78 (2309) | Hitachi Ltd, Japan | JPN | |
| 79 (2315) | GE Healthcare, China | CHN | |
| 80 (2465) | Siemens Healthineers, Germany | DEU | |
| 81 (2481) | GeneDx | USA | |
| 82 (2490) | Siemens AG, China | CHN | |
| 83 (2494) | RTI Health Solutions * | MUL | |
| 84 (2501) | IQVIA, Germany | DEU | |
| 85 (2526) | RTI Health Solutions, United States | USA | |
| 86 (2549) | Siemens Healthineers, China | CHN | |
| 87 (2551) | Philips Healthcare, China | CHN | |
| 88 (2581) | Keralty * | COL | |
|
